PerkinElmer (PKI) : Sensato Investors reduced its stake in PerkinElmer by 5.05% during the most recent quarter end. The investment management company now holds a total of 293,300 shares of PerkinElmer which is valued at $15,958,453 after selling 15,600 shares in PerkinElmer , the firm said in a disclosure report filed with the SEC on Aug 15, 2016.PerkinElmer makes up approximately 2.65% of Sensato Investors’s portfolio.
Other Hedge Funds, Including , Capital Research Global Investors reduced its stake in PKI by selling 3,000,000 shares or 24.79% in the most recent quarter. The Hedge Fund company now holds 9,102,000 shares of PKI which is valued at $495,239,820. PerkinElmer makes up approx 0.16% of Capital Research Global Investors’s portfolio.Hsbc Holdings Plc boosted its stake in PKI in the latest quarter, The investment management firm added 201 additional shares and now holds a total of 38,194 shares of PerkinElmer which is valued at $2,078,136. PerkinElmer makes up approx 0.01% of Hsbc Holdings Plc’s portfolio.Edmond De Rothschild Asset Management (france) reduced its stake in PKI by selling 17,600 shares or 9.28% in the most recent quarter. The Hedge Fund company now holds 172,000 shares of PKI which is valued at $9,358,520. PerkinElmer makes up approx 0.42% of Edmond De Rothschild Asset Management (france)’s portfolio.Advisors Asset Management reduced its stake in PKI by selling 4,831 shares or 5.7% in the most recent quarter. The Hedge Fund company now holds 79,924 shares of PKI which is valued at $4,373,441. PerkinElmer makes up approx 0.07% of Advisors Asset Management’s portfolio.
PerkinElmer opened for trading at $53.27 and hit $53.53 on the upside on Thursday, eventually ending the session at $53.26, with a gain of 0.02% or 0.01 points. The heightened volatility saw the trading volume jump to 4,89,953 shares. Company has a market cap of $5,827 M.
On the company’s financial health, PerkinElmer reported $0.67 EPS for the quarter, beating the analyst consensus estimate by $ 0.01 according to the earnings call on Aug 4, 2016. Analyst had a consensus of $0.66. The company had revenue of $573.00 million for the quarter, compared to analysts expectations of $575.66 million. The company’s revenue was up 1.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.60 EPS.
Many Wall Street Analysts have commented on PerkinElmer. Mizuho Downgraded PerkinElmer on Aug 5, 2016 to ” Neutral”, Price Target of the shares are set at $56.
PerkinElmer Inc. is a provider of products services and solutions to the diagnostics research environmental industrial and laboratory services markets. The Company operates its business in two segments: Human Health and Environmental Health. The Companys Human Health segment concentrates on developing diagnostics tools and applications to help detect diseases earlier and more accurately and to accelerate the discovery and development of new therapies. The Companys Environmental Health segment provides products services and solutions to facilitate the creation of safer food and consumer products more secure surroundings and efficient energy resources. The Company markets its products and services in more than 150 countries.